COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,550 Articles (22,881 medRxiv, 8,669 bioRxiv)

Most recent first Previous |  Page 487: Articles 4861-4870  | Next

Analysis of spike protein variants evolved in a novel mouse model of persistent SARS-CoV-2 infection
Kim, D., Kim, J., Kim, M., Park, H., Maharjan, S., Baek, K., Kang, B. M., Kim, S., Park, S., Park, M.-S., Lee, Y., Kwon, H.-J.
10.1101/2023.03.19.533317 — Posted: 2023-03-20
SARS-CoV-2 NSP12 associates with the TRiC complex and the P323L substitution is a host adaption.
Alruwaili, M., Armstrong, S., Prince, T., Erdmann, M., Davidson, A. D., Matthews, D. A., AlJabr, W., Hiscox, J. A.
10.1101/2023.03.18.533280 — Posted: 2023-03-20
Coronavirus endoribonuclease nsp15 induces host cellular protein synthesis shutoff
Liao, Y., Gong, X., Feng, S., Gao, B., Fang, S., Weng, W., Chu, H., Yuan, Y., Cheng, Y., Sun, Y., Tan, L., Song, C., Qiu, X., Ding, C., Liao, M., Tijhaar, E., Forlenza, M.
10.1101/2023.03.20.533404 — Posted: 2023-03-20
Mouse Adapted SARS-CoV-2 Model Induces "Long-COVID" Neuropathology in BALB/c Mice
Gressett, T. E., Leist, S. R., Ismael, S., Talkington, G., Dinnon, K. H., Baric, R. S., Bix, G.
10.1101/2023.03.18.533204 — Posted: 2023-03-20
Enhanced protective efficacy of a novel, thermostable, RBD-S2 fusion immunogen against SARS-CoV-2 and its variants
Mittal, N., Kumar, S., Rajmani, R. S., Singh, R., Lemoine, C., Jakob, V., BJ, S., Bhat, M., Chakraborty, D., Pandey, S., Jory, A., S.A., S. S., Kleanthous, H., Dubois, P., Ringe, R. P., Varadarajan, R.
10.1101/2023.03.19.533338 — Posted: 2023-03-20
Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix study
Reichmuth, M. L., Heron, L., Riou, J., Moser, A., Hauser, A., Low, N., Althaus, C. L.
10.1101/2023.03.13.23287183 — Posted: 2023-03-20
Reconstructing the first COVID-19 pandemic wave with minimal data
Chen, S., White, L. J.
10.1101/2023.03.17.23287140 — Posted: 2023-03-20
Single-cell transcriptomics identifies different immune signatures between macrophage activation-like syndrome and immune paralysis in sepsis
Grondman, I., Koeken, V., Karageorgos, A., LI, W., Antonakos, N., Zhang, B., Damoraki, G., Xu, C.-J., Giamarellos-Bourboulis, E., Li, Y., Netea, M.
10.1101/2023.03.17.23287390 — Posted: 2023-03-20
Reduced control of SARS-CoV-2 infection is associated with lower mucosal antibody responses in pregnant women
St Clair, L. A., Eldesouki, R. E., Sachithanandham, J., Yin, A., Fall, A., Morris, C. P., Norton, J. M., Forman, M., Abdullah, O., Dhakal, S., Barranta, C., Golding, H., Bersoff-Matcha, S. J., Pilgrim-Grayson, C., Berhane, L., Cox, A. L., Burd, I., Pekosz, A., Mostafa, H. H., Klein, E., Klein, S. L.
10.1101/2023.03.19.23287456 — Posted: 2023-03-20
First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody
Omidvari, N., Jones, T., Price, P. M., Ferre, A. L., Lu, J., Abdelhafez, Y. G., Sen, F., Cohen, S. H., Schmiedehausen, K., Badawi, R. D., Shacklett, B. L., Wilson, I., Cherry, S. R.
10.1101/2023.03.14.23287121 — Posted: 2023-03-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).